Crick
HomeTrialsGenesDrugs23andMeGraphBlogContact
  • Home
  • Trials
  • Genes
  • Drugs
  • 23andMe
  • Graph
  • Blog
  • Contact
Crick

An open-source clinical intelligence platform. Explore clinical trials, gene networks, and molecular structures using public data sources.

Data Sources

  • ClinicalTrials.gov
  • OpenTargets
  • ClinVar
  • PubChem

Links

  • Contact
  • Privacy

© 2026 Crick. All rights reserved.

Crick is for educational purposes only. Not medical advice.

Results for “Squamous Cell Carcinomas”

Filters

Phase
Early Phase 1
Phase 1
Phase 2
Phase 3
Phase 4
Status
Recruiting
Active, Not Recruiting
Not Yet Recruiting
Completed
Enrolling by Invitation

Showing 20 of 0 results

Testing effectiveness (Phase 2)UnknownNCT02624128
What this trial is testing

Valproic Acid Plus Cisplatin and Cetuximab in Recurrent and/or Metastatic Squamous Cell Carcinoma of Head and Neck

Who this might be right for
Squamous Cell Carcinoma of the Head and Neck
National Cancer Institute, Naples 39
Large-scale testing (Phase 3)Study completedNCT03676192
What this trial is testing

To Compare Efficacy and Safety of CT-P16 and European Union-Approved Avastin as First-Line Treatment for Metastatic or Recurrent Non-Squamous Non-Small Cell Lung Cancer

Who this might be right for
Adenocarcinoma of Lung
Celltrion 689
Not applicableActive Not RecruitingNCT06327971
What this trial is testing

Enhanced Outcome Prediction in Cutaneous Squamous Cell Carcinoma Using Deep-learning and Computational Histopathology

Who this might be right for
Squamous Cell Carcinoma of the Skin
Queen Mary University of London 300
Not applicableWithdrawnNCT02162641
What this trial is testing

Study to Determine the Feasibility of Sentinel Node Biopsy in Patients With Anal Cancer

Who this might be right for
Squamous Cell Carcinoma of the Anus
The Christie NHS Foundation Trust
Large-scale testing (Phase 3)Study completedNCT02027428
What this trial is testing

Safety and Efficacy Study of Abraxane as Maintenance Treatment After Abraxane Plus Carboplatin in 1st Line Stage IIIB / IV Squamous Cell Non-small Cell Lung Cancer

Who this might be right for
Squamous Cell Carcinoma, Non-Small-Cell Lung
Celgene 427
Very early researchNot Yet RecruitingNCT07741565
What this trial is testing

Window Trial of Intratumoral (IT) Neoadjuvant Fluorescently Labelled Nivolumab (nivo800) in Head and Neck Squamous Cell Carcinoma (HNSCC)

Who this might be right for
HNSCCSCC - Squamous Cell CarcinomaOral Cancer
Vanderbilt-Ingram Cancer Center 18
Large-scale testing (Phase 3)Looking for participantsNCT07580300
What this trial is testing

Proton Versus Photon Therapy in Head and Neck Squamous Cell Carcinomas.

Who this might be right for
HNSCC
Oslo University Hospital 400
Testing effectiveness (Phase 2)Ended earlyNCT01794845
What this trial is testing

Cetuximab + Taxotere With Low Dose Fractionated Radiation for Head and Neck Carcinoma

Who this might be right for
Squamous Cell CarcinomaHead and Neck CancerRecurrent Disease
University of Miami 5
Testing effectiveness (Phase 2)Active Not RecruitingNCT05054439
What this trial is testing

A Clinical Study of SI-B001 in Combination With Paclitaxel/Docetaxel in the Treatment of Recurrent and Metastatic HNSCC

Who this might be right for
Head and Neck Squamous Cell Carcinoma
Sichuan Baili Pharmaceutical Co., Ltd. 45
Not applicableEnded earlyNCT03276819
What this trial is testing

A Clinical and Biological Umbrella Protocol for Smoker or Non-smoker Patients With OPML or HNSCC

Who this might be right for
Premalignant LesionHead and Neck Squamous Cell Carcinoma (HNSCC)
Centre Leon Berard 53
Early research (Phase 1)UnknownNCT05780307
What this trial is testing

IMM2520, a PD-L1 and CD47 Bispecific Antibody in Patients With Advanced Solid Tumors

Who this might be right for
Advanced Solid TumorNon-small Cell Lung CancerSmall Cell Lung Cancer+3 more
ImmuneOnco Biopharmaceuticals (Shanghai) Inc. 48
Not applicableUnknownNCT04218136
What this trial is testing

Cetuximab Therapeutic Drug Monitoring in Squamous Cell Carcinoma Head and Neck Cancer Patients: Determination of the Predictive Value Exposure Levels Through a Single Arm Multicentric Study

Who this might be right for
Head and Neck Cancer
Assistance Publique Hopitaux De Marseille 122
Testing effectiveness (Phase 2)Active Not RecruitingNCT04291105
What this trial is testing

Phase 2 Trial of Voyager V1 in Combination With Cemiplimab in Cancer Patients

Who this might be right for
MelanomaHead and Neck Squamous Cell CarcinomaColo-rectal Cancer
Vyriad, Inc. 87
Early research (Phase 1)Looking for participantsNCT07219212
What this trial is testing

JNJ-90301900 in Combination With Chemoradiation Therapy in Participants With Locally Advanced Head and Neck Squamous Cell Carcinoma

Who this might be right for
Squamous Cell Carcinoma of Head and Neck
Johnson & Johnson Enterprise Innovation Inc. 45
Testing effectiveness (Phase 2)Looking for participantsNCT05286619
What this trial is testing

Pembrolizumab (MK-3475) Plus Platinum and Gemcitabine as First Line Treatment of Recurrent/Metastatic Head and Neck Squamous Cell Carcinoma (PIPER)

Who this might be right for
Recurrent/Metastatic Head and Neck Squamous Cell Carcinoma
University of Malaya 63
Testing effectiveness (Phase 2)Study completedNCT01695122
What this trial is testing

Valproic Acid and Platinum-based Chemoradiation in Locally Advanced Head and Neck Squamous Cell Carcinoma

Who this might be right for
Head and Neck CancerOral Cavity CancerOropharyngeal Cancer
Instituto do Cancer do Estado de São Paulo 14
Early research (Phase 1)Ended earlyNCT04000529
What this trial is testing

Phase Ib Study of TNO155 in Combination With Spartalizumab or Ribociclib in Selected Malignancies

Who this might be right for
Non-small Cell Lung CarcinomaHead and Neck Squamous Cell CarcinomaEsophageal SCC+2 more
Novartis Pharmaceuticals 122
Not applicableStudy completedNCT04030130
What this trial is testing

Navigation vs Usual Care for Timely Adjuvant Therapy for Patients With Locally Advanced HNSCC

Who this might be right for
Squamous Cell Carcinoma of Head and Neck
Medical University of South Carolina 176
Testing effectiveness (Phase 2)Active Not RecruitingNCT04625647
What this trial is testing

Testing the Use of Targeted Treatment (AMG 510) for KRAS G12C Mutated Advanced Non-squamous Non-small Cell Lung Cancer (A Lung-MAP Treatment Trial)

Who this might be right for
Lung AdenocarcinomaLung Non-Small Cell CarcinomaRecurrent Lung Non-Squamous Non-Small Cell Carcinoma+3 more
SWOG Cancer Research Network 116
Testing effectiveness (Phase 2)UnknownNCT00008047
What this trial is testing

Combination Chemotherapy Combined With Radiation Therapy in Treating Patients Who Have Stage II or Stage III Cancer of the Esophagus

Who this might be right for
Esophageal Cancer
GERCOR - Multidisciplinary Oncology Cooperative Group
Next Page